Funding for this research was provided by:
Universitätsklinikum Regensburg
Article History
Received: 1 May 2024
Accepted: 5 September 2024
First Online: 17 September 2024
Declarations
:
: The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Regensburg (number, 20-1810-101, date, February 10, 2021). Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Wolff Daniel received research support from Novartis and honoraria from Novartis, Sanofi, Incyte, Behring, Neovii, Takeda and Mallinckrodt.